These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31735060)

  • 21. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of urinary AD7c-NTP for diagnosing Alzheimer's disease: a systematic review and meta-analysis.
    Zhang J; Zhang CH; Li RJ; Lin XL; Chen YD; Gao HQ; Shi SL
    J Alzheimers Dis; 2014; 40(1):153-9. PubMed ID: 24346218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Distribution of Urinary Alzheimer-Associated Neuronal Thread Protein and Its Association with Common Chronic Diseases in the General Population.
    Jin H; Guan S; Wang R; Fang X; Liu H; Wu Y; Zhang Y; Liu C
    J Alzheimers Dis; 2018; 65(2):433-442. PubMed ID: 30040733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential and subtype-specific neuroimaging abnormalities in amnestic and nonamnestic mild cognitive impairment: A systematic review and meta-analysis.
    Yeung MK; Chau AK; Chiu JY; Shek JT; Leung JP; Wong TC
    Ageing Res Rev; 2022 Sep; 80():101675. PubMed ID: 35724862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Pramipexole Combined with Nerve Growth Factor on Cognitive Impairment and Urinary AD7c-NTP Expression in Patients with Parkinson's Disease.
    Wang Z; Cheng S
    Comput Math Methods Med; 2022; 2022():3398732. PubMed ID: 35516456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.
    Eliassen CF; Reinvang I; Selnes P; Grambaite R; Fladby T; Hessen E
    Brain Behav; 2017 Sep; 7(9):e00776. PubMed ID: 28948074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease.
    Munzar M; Levy S; Rush R; Averback P
    Neurol Clin Neurophysiol; 2002; 2002(1):2-8. PubMed ID: 12028823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E ϵ4 genotype.
    Wang C; Cui Y; Yang J; Zhang J; Yuan D; Wei Y; Li Y; Duo Y; Li S; Zhu W; Zheng L
    Biomarkers; 2015 Feb; 20(1):84-8. PubMed ID: 25532446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary AD7c-NTP is Associated With Cognitive Recovery After Ischemic Stroke.
    Wang Y; Tao H; Cao M; Cai K
    Alzheimer Dis Assoc Disord; 2024 Jul-Sep 01; 38(3):292-294. PubMed ID: 39107927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
    Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
    Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between cognitive reserve, brain volume, and neuropsychological performance in amnestic and nonamnestic MCI.
    Reiter K; Butts AM; Janecek JK; Correro AN; Nencka A; Agarwal M; Franczak M; Glass Umfleet L
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):940-956. PubMed ID: 36573001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.
    Oltra-Cucarella J; Ferrer-Cascales R; Alegret M; Gasparini R; Díaz-Ortiz LM; Ríos R; Martínez-Nogueras ÁL; Onandia I; Pérez-Vicente JA; Cabello-Rodríguez L; Sánchez-SanSegundo M
    Psychol Aging; 2018 Nov; 33(7):1007-1021. PubMed ID: 30284855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The AD7C-NTP neuronal thread protein biomarker for detecting Alzheimer's disease.
    de la Monte SM; Wands JR
    Front Biosci; 2002 Apr; 7():d989-96. PubMed ID: 11897561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shared and specific dynamics of brain activity and connectivity in amnestic and nonamnestic mild cognitive impairment.
    Zhong X; Chen B; Hou L; Wang Q; Liu M; Yang M; Zhang M; Zhou H; Wu Z; Zhang S; Lin G; Ning Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2053-2065. PubMed ID: 35975454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
    Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
    J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.